The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Mechanisms of vancomycin resistance in Staphylococcus aureus
Open accessAbstract
Vancomycin is a glycopeptide antibiotic used for the treatment of Gram-positive bacterial infections. Traditionally, it has been used as a drug of last resort; however, clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) strains with decreased susceptibility to vancomycin (vancomycin intermediate-resistant S. aureus [VISA]) and more recently with high-level vancomycin resistance (vancomycin-resistant S. aureus [VRSA]) have been described in the clinical literature. The rare VRSA strains carry transposon Tn1546, acquired from vancomycin-resistant Enterococcus faecalis, which is known to alter cell wall structure and metabolism, but the resistance mechanisms in VISA isolates are less well defined. Herein, we review selected mechanistic aspects of resistance in VISA and summarize biochemical studies on cell wall synthesis in a VRSA strain. Finally, we recapitulate a model that integrates common mechanistic features of VRSA and VISA strains and is consistent with the mode of action of vancomycin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phenotypically, hVISA/VISA strains exhibit distinct metabolic characteristics that may include i) increase in fructose utilization, ii) increased fatty acid metabolism, iii) impaired acetate metabolism and tricarboxylic acid cycle, iv) decrease in glutamate availability, and iv) increase expression of cell wall synthesis genes.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“However, the available evidence shows that the regulatory systems most consistently implicated in this mechanism of resistance are YycFG (WalKR), VraSR (homolog of LiaFSR), and GraRS (104).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“These global homeostatic changes appear to lead to a reduced autolytic activity with thickened cell wall and an increase amount of free D-Ala-D-Ala dipeptides with less peptidoglycan cross-linking (101, 104).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“In addition, VISA strains bind vancomycin more avidly than their non –VISA counterparts, however, diffusion of the antibiotic molecule into the inner part of the cell wall appears to be impaired.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
In the citing paper
“Finally, a striking feature of many hVISA/VISA strains is the ability to revert from one phenotype to another (or even to a fully vancomycin susceptible phenotype) in the absence of vancomycin exposure.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Emergence of Vancomycin Resistance inStaphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,086
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Levine, D. P. (2005) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 883
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 761
Genetics and mechanisms of glycopeptide resistance in enterococci
Arthur, M., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1563 · Cited by 692
Sieradzki, K., Roberts, R. B., Haber, S. W., & Tomasz, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400704 · Cited by 638
Self-citationMwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de LENCASTRE, H., Richardson, P., Bruce, D. G., Rubin, E. M., Myers, E. W., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538
Self-citationReemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. “. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 522
Kuroda, M., Kuroda, H., Oshima, T., Takeuchi, F., Mori, H., & Hiramatsu, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03599.x · Cited by 515
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Antimicrobial Resistance in ESKAPE Pathogens
Oliveira, D. M. P. D., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,243
Methicillin-resistant Staphylococcus aureus
Lee, A. S., de LENCASTRE, H., Garau, J., Kluytmans, J. A. J. W., Malhotra‐Kumar, S., Peschel, A., & Harbarth, S. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.33 · Cited by 1,691
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,352
Comprehensive review of antimicrobial activities of plant flavonoids
Górniak, I., Bartoszewski, R., & Króliczewski, J. (2018) · Phytochemistry Reviews · doi:10.1007/s11101-018-9591-z · Cited by 1,268
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
Guo, Y., Song, G., Meiling, S., Wang, J., & Wang, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00107 · Cited by 903
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 930
Horizontal transfer of antibiotic resistance genes in clinical environments
Lerminiaux, N. A., & Cameron, A. D. S. (2018) · Canadian Journal of Microbiology · doi:10.1139/cjm-2018-0275 · Cited by 868
Cong, Y., Yang, S., & Rao, X. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 571
Antibiotic Resistance and the MRSA Problem
Vestergaard, M. R., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 540
Mechanisms of antibiotic resistance
Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Medina, E., & Pieper, D. H. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_492 · Cited by 376
Shariati, A., Dadashi, M., Moghadam, M. T., van Belkum, A., Yaslianifard, S., & Darban‐Sarokhalil, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-69058-z · Cited by 348
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
Gajdács, M. (2019) · Antibiotics · doi:10.3390/antibiotics8020052 · Cited by 323
History of antimicrobial drug discovery: Major classes and health impact
Aminov, R. I. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.001 · Cited by 318
Envelope Structures of Gram-Positive Bacteria
Rajagopal, M., & Walker, S. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5021 · Cited by 318
Developments in Glycopeptide Antibiotics
Blaskovich, M. A. T., Hansford, K. A., Butler, M. S., Jia, Z., Mark, A. E., & Cooper, M. A. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00258 · Cited by 270
Ultrasensitive Detection of Bacteria Using a 2D MOF Nanozyme-Amplified Electrochemical Detector
Hu, W., Pang, J., Biswas, S., Wang, K., Wang, C., & Xia, X. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01261 · Cited by 239
Kakoullis, L., Papachristodoulou, E., Chra, P., & Panos, G. Z. (2021) · Antibiotics · doi:10.3390/antibiotics10040415 · Cited by 269
Mechanisms of drug resistance: daptomycin resistance
Tran, T. T., Munita, J. M., & Arias, C. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12948 · Cited by 244
Kashani, H. H., Schmelcher, M., Sabzalipoor, H., Hosseini, E. S., & Moniri, R. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00071-17 · Cited by 234
Recent Developments in Antimicrobial Polymers: A Review
Santos, M. R. E., Fonseca, A. C., Mendonça, P. V., Branco, R., Serra, A. C., Morais, P. V., & Coelho, J. F. J. (2016) · Materials · doi:10.3390/ma9070599 · Cited by 219
4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads
Gatadi, S., Lakshmi, T. V., & Nanduri, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.018 · Cited by 209
Geisinger, E., & Isberg, R. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw402 · Cited by 199
Zhang, Y., Zhang, J., Chen, W., Angsantikul, P., Spiekermann, K., Fang, R. H., Gao, W., & Zhang, L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.016 · Cited by 194
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 254
Biodegradation of antibiotics: The new resistance determinants – part I
Reis, A. C., Kolvenbach, B. A., Nunes, O. C., & Corvini, P. F.-X. (2019) · New Biotechnology · doi:10.1016/j.nbt.2019.08.002 · Cited by 199
A review on nanosystems as an effective approach against infections of Staphylococcus aureus
Zhou, K., Li, C., Chen, D., Pan, Y., Tao, Y., Qu, W., Liu, Z., Wang, X., & Xie, S. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s169935 · Cited by 164
Vancomycin Resistance in Enterococcus and Staphylococcus aureus
Li, G., Walker, M. J., & Oliveira, D. M. P. D. (2022) · Microorganisms · doi:10.3390/microorganisms11010024 · Cited by 161
Okwu, M. U., Olley, M., Akpoka, O. A., & Izevbuwa, O. E. (2019) · AIMS Microbiology · doi:10.3934/microbiol.2019.2.117 · Cited by 153
Application and Perspectives of MALDI–TOF Mass Spectrometry in Clinical Microbiology Laboratories
Torres-Sangiao, E., Rodríguez, C. L., & García-Riestra, C. (2021) · Microorganisms · doi:10.3390/microorganisms9071539 · Cited by 147
Evolving Resistance Among Gram-positive Pathogens
Munita, J. M., Bayer, A. S., & Arias, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ523 · Cited by 134
Gnanamani, A., Periasamy, H., & Satyaseela, M. P. (2017) · InTech eBooks · doi:10.5772/67338 · Cited by 141
Venter, H., Henningsen, M. L., & Neville, S. L. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160053 · Cited by 138
β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium
Fisher, J. F., & Mobashery, S. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01010 · Cited by 128
Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us
Kong, E. F., Johnson, J. K., & Jabra‐Rizk, M. A. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005837 · Cited by 122
An Insight Into the Potentiation Effect of Potassium Iodide on aPDT Efficacy
Vieira, C., Gomes, A. T. P. C., Mesquita, M. Q., Moura, N. M. M., Neves, M. G. P. M. S., Faustino, M. A. F., & Almeida, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02665 · Cited by 124
Ghaffar, I., Imran, M., Perveen, S., Kanwal, T., Saifullah, S., Bertino, M. F., Ehrhardt, C. J., Yadavalli, V. K., & Shah, M. R. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110111 · Cited by 120
Wang, Z., Zheng, P., Ji, W., Fu, Q., Wang, H., Yan, Y., & Sun, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00934 · Cited by 113
Peck, M. C., Rothenberg, M. E., Deng, R., Lewin‐Koh, N., She, G., Kamath, A. V., Carrasco‐Triguero, M., Saad, O. M., Castro, A., Teufel, L. U., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02588-18 · Cited by 114
Hasan, R., Acharjee, M., & Noor, R. (2016) · Tzu Chi Medical Journal · doi:10.1016/j.tcmj.2016.03.002 · Cited by 110
Triple threat: how diabetes results in worsened bacterial infections
Darwitz, B. P., Genito, C. J., & Thurlow, L. R. (2024) · Infection and Immunity · doi:10.1128/iai.00509-23 · Cited by 137
Schneider, Y. K.-H. (2021) · Antibiotics · doi:10.3390/antibiotics10070842 · Cited by 107
Huang, R., Cai, G.-Q., Li, J., Li, X., Liu, H., Shang, X., Zhou, J., Nie, X., & Gui, R. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00978-2 · Cited by 103
Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
Foster, T. J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.06.005 · Cited by 106
Li, L., Cao, S., Wu, Z., Guo, R., Xie, L., Wang, L., Tang, Y., Li, Q., Luo, X., Ma, L., et al. (2022) · Advanced Materials · doi:10.1002/adma.202108646 · Cited by 102
Acquired Bacterial Resistance to Antibiotics and Resistance Genes: From Past to Future
Galgano, M., Pellegrini, F., Catalano, E., Capozzi, L., Sambro, L. D., Sposato, A., Lucente, M. S., Vasinioti, V. I., Catella, C., Odigie, A. E., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14030222 · Cited by 118
Biodegradation of antibiotics: The new resistance determinants – part II
Reis, A. C., Kolvenbach, B. A., Nunes, O. C., & Corvini, P. F.-X. (2019) · New Biotechnology · doi:10.1016/j.nbt.2019.08.003 · Cited by 100
The role of Staphylococcus aureus quorum sensing in cutaneous and systemic infections
Yamazaki, Y., Ito, T., Tamai, M., Nakagawa, S., & Nakamura, Y. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00323-8 · Cited by 101
Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options
Chalmers, S. J., & Wylam, M. E. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9849-4_16 · Cited by 93
Almeida, L., Dhillon-LaBrooy, A., Castro, C. N., Adossa, N. A., Carriche, G. M., Guderian, M., Lippens, S., Dennerlein, S., Hesse, C., Lambrecht, B. N., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.001 · Cited by 91
O’Brien, F. G., Eto, K. Y., Murphy, R. J. T., Fairhurst, H. M., Coombs, G. W., Grubb, W. B., & Ramsay, J. P. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv755 · Cited by 86
Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review
Françoise Van Bambeke, A. (2015) · Drugs · doi:10.1007/s40265-015-0505-8 · Cited by 88
Controlled Delivery of Vancomycin via Charged Hydrogels
Gustafson, C. T., Boakye‐Agyeman, F., Brinkman, C. L., Reid, J. M., Patel, R., Bajzer, Ž., Dadsetan, M., & Yaszemski, M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146401 · Cited by 83
A potent antibiotic-loaded bone-cement implant against staphylococcal bone infections
Ghosh, S., Sinha, M., Samanta, R., Sadhasivam, S., Bhattacharyya, A., Nandy, A., Saini, S., Tandon, N., Singh, H., Gupta, S., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00950-x · Cited by 82
Shekarabi, M., Hajikhani, B., Chirani, A. S., Fazeli, M., & Goudarzi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183607 · Cited by 83
Sobczak‐Kupiec, A., Drabczyk, A., Florkiewicz, W., Głąb, M., Kudłacik‐Kramarczyk, S., Słota, D., Tomala, A. M., & Tyliszczak, B. (2021) · Materials · doi:10.3390/ma14092096 · Cited by 84
Mechanisms of antimicrobial resistance among hospital-associated pathogens
Khan, A., Miller, W. R., & Arias, C. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1456919 · Cited by 82
Local Injection of Aminoglycosides for Prophylaxis Against Infection in Open Fractures
Lawing, C., Lin, F., & Dahners, L. E. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.o.00072 · Cited by 76
Photoinactivation of ESKAPE Pathogens: Overview of Novel Therapeutic Strategy
Nakonieczna, J., Woźniak, A., Pierański, M. K., Rapacka-Zdończyk, A., Ogonowska, P., & Grinholc, M. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0329 · Cited by 75
Fodor, A., Abate, B. A., Deák, P., Fodor, L., Gyenge, E., Klein, M. G., Koncz–Kálmán, Z., Muvevi, J., Otvos, L. J., Székely, G., et al. (2020) · Pathogens · doi:10.3390/pathogens9070522 · Cited by 78
Investigational drugs to treat methicillin-resistantStaphylococcus aureus
Vuong, C., Yeh, A. J., Cheung, G. Y. C., & Otto, M. J. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1109077 · Cited by 76
Vancomycin dosing, monitoring and toxicity: Critical review of the clinical practice
Zamoner, W., Prado, I. R. S., Balbi, A. L., & Ponce, D. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13066 · Cited by 73
Jousselin, A., Manzano, C., Biette, A., Reed, P., Pinho, M. G., Rosato, A. E., Kelley, W. L., & Renzoni, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02333-15 · Cited by 69
Sahibzada, M. U. K., Sadiq, A., Khan, S., Faidah, H. S., Ullah, N., Khurram, M., Amin, M. U., & Haseeb, A. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s133806 · Cited by 69
David, M. Z., Dryden, M., Gottlieb, T., Tattevin, P., & Gould, I. M. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.006 · Cited by 69
Gatadi, S., Gour, J., Shukla, M., Kaul, G., Das, S., Dasgupta, A., Malasala, S., Borra, R. S., Madhavi, Y. V., Chopra, S., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.070 · Cited by 69
Zhang, S., Liao, X., Ding, T., & Ahn, J. (2024) · Antibiotics · doi:10.3390/antibiotics13030260 · Cited by 87
Pfaller, M. A., Mendes, R. E., Duncan, L. R., Flamm, R. K., & Sader, H. S. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky235 · Cited by 68
Phytochemicals with activity against methicillin-resistant Staphylococcus aureus
Liang, M., Ge, X., Xua, H., Ma, K., Zhang, W., Zan, Y., Efferth, T., Xue, Z., & Hua, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154073 · Cited by 67
Orlanda, J. F. F., & Nascimento, A. R. (2015) · South African Journal of Botany · doi:10.1016/j.sajb.2015.03.198 · Cited by 66
Ziesmer, J., Tajpara, P., Hempel-Højgaard, N.-J., Ehrström, M., Melican, K., Eidsmo, L., & Sotiriou, G. A. (2021) · Advanced Materials Technologies · doi:10.1002/admt.202001307 · Cited by 67
Raman‐activated sorting of antibiotic‐resistant bacteria in human gut microbiota
Wang, Y., Xu, J., Kong, L., Li, B., Li, H., Huang, W. E., & Zheng, C. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.14962 · Cited by 63
Bissong, M. E. A., & Ateba, C. N. (2020) · Antibiotics · doi:10.3390/antibiotics9040156 · Cited by 62
Promising antibacterial agents against multidrug resistant Staphylococcus aureus
Gatadi, S., Yaddanapudi, V. M., Chopra, S., & Nanduri, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103252 · Cited by 62
Actinobacteria –Derived peptide antibiotics since 2000
Zhao, P., Xue, Y., Gao, W., Li, J., Zu, X., Fu, D., Feng, S., Bai, X., Zuo, Y., & Li, P. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.011 · Cited by 61
Almuhayawi, M. S., Alruhaili, M. H., Gattan, H. S., Alharbi, M. T., Nagshabandi, M. K., Jaouni, S. K. A., Selim, S., Alanazi, A., Alruwaili, Y. S., Faried, O. A., et al. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s418681 · Cited by 62
Aggregated Amphiphilic Antimicrobial Peptides Embedded in Bacterial Membranes
Gong, H., Liao, M., Hu, X., Fa, K., Phanphak, S., Ciumac, D., Hollowell, P., Shen, K., Clifton, L. A., Campana, M., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09931 · Cited by 59
The Impact of Hypoxia on the Host-Pathogen Interaction between Neutrophils and Staphylococcus aureus
Hajdamowicz, N. H., Hull, R. C., Foster, S. J., & Condliffe, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225561 · Cited by 61
Ijaz, M. U. (2021) · Pakistan Veterinary Journal · doi:10.29261/pakvetj/2021.060 · Cited by 58
Brambilla, I. D. P. R., Pinto, J. G., Souza, B. M. N., Miñán, A., & Ferreira–Strixino, J. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102729 · Cited by 58
Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus
Lade, H. S., Joo, H., & Kim, J. (2022) · Antibiotics · doi:10.3390/antibiotics11101378 · Cited by 64
Beyar‐Katz, O., Dickstein, Y., Borok, S., Vidal, L., Leibovici, L., & Paul, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003914.pub4 · Cited by 58
Beyond Vancomycin: The Tail of the Lipoglycopeptides
Klinker, K. P., & Borgert, S. J. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.11.007 · Cited by 58
Ferreira, G. R. S., Brito, J. D. S., Procópio, T. F., Santos, N. D. D. L., de Lima, B. J. R. C., Coelho, L. C. B. B., Navarro, D. M. D. A. F., Paiva, P. M. G., Soares, T., de Moura, M. C., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.08.027 · Cited by 61
Pajares‐Chamorro, N., Wagley, Y., Maduka, C. V., Youngstrom, D. W., Yeger, A., Badylak, S. F., Hammer, N. D., Hankenson, K. D., & Chatzistavrou, X. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111693 · Cited by 57
Foxley, M. A., Friedline, A. W., Jensen, J. M., Nimmo, S. L., Scull, E. M., King, J. B., Strange, S., Xiao, M. T., Smith, B. E., Thomas, K. J., III, et al. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.44 · Cited by 57
Silverman, S. M., Moses, J. E., & Sharpless, K. B. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604765 · Cited by 58
Adhikari, R., Pant, N. D., Neupane, S. R., Neupane, M., Bhattarai, R., Bhatta, S., Chaudhary, R., & Lekhak, B. (2017) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2017/2191532 · Cited by 58
Emerging nanotechnologies for targeting antimicrobial resistance
Weldrick, P. J., Wang, A., Halbus, A. F., & Paunov, V. N. (2022) · Nanoscale · doi:10.1039/d1nr08157h · Cited by 55
Weldrick, P. J., Iveson, S., Hardman, M. J., & Paunov, V. N. (2019) · Nanoscale · doi:10.1039/c8nr10022e · Cited by 59
Antimicrobial resistance three ways: healthcare crisis, major concepts and the relevance of biofilms
Jorge, P., Magalhães, A. P., Grainha, T., Alves, D. F., Sousa, A. M., Lopes, S. P., & Pereira, M. O. (2019) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiz115 · Cited by 59
Mashruwala, A. A., Bhatt, S., Poudel, S., Boyd, E. S., & Boyd, J. M. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006233 · Cited by 53
Hagbani, T. A., Yadav, V. K., Moin, A., Lila, A. S. A., Mehmood, K., Alshammari, F., Khan, S., Khafagy, E., Hussain, T., Rizvi, S. M. D., et al. (2022) · Materials · doi:10.3390/ma15031108 · Cited by 54
Antibiotic Resistance and the MRSA Problem
Vestergaard, M. R., Frees, D., & Ingmer, H. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch47 · Cited by 53
Ma, Z., Han, J., Chang, B., Gao, L., Lu, Z., Lü, F., Zhao, H., Zhang, C., & Bie, X. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00100 · Cited by 51
Abdelraheem, W. M., Khairy, R. M. M., Zaki, A. I., & Zaki, S. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00459-2 · Cited by 50
A comprehensive review of recent advances in the biological activities of quinazolines
Gomaa, H. A. M. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14129 · Cited by 49
Raza, S., Wdowiak, M., Grotek, M., Adamkiewicz, W., Nikiforow, K., Mente, P., & Paczesny, J. (2023) · Nanoscale Advances · doi:10.1039/d3na00220a · Cited by 50
Metadata
- Authors
- Gardete, S., & Tomasz, A.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Tomasz, Alexander
- Venue
- Journal of Clinical Investigation
- Published
- 2014-07-01
- Volume
- 124
- Issue
- 7
- Pages
- 2836-2840
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4071404
- OpenAlex
- W1983784984
- Cited by
- 565
- References
- 66
- Citations by year
- 2026: 26 · 2025: 53 · 2024: 71 · 2023: 48 · 2022: 53 · 2021: 57 · 2020: 49 · 2019: 66 · 2018: 40 · 2017: 43 · 2016: 29 · 2015: 25 · 2014: 4
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (2 R01 AI457838-14)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- vancomycin resistance, Staphylococcus aureus, vancomycin-intermediate Staphylococcus aureus, vancomycin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Tn1546 transposon, vancomycin-resistant Enterococcus faecalis, cell wall biosynthesis, glycopeptides, antibiotic resistance mechanisms, cell wall metabolism
- MeSH terms
- Cell Wall, DNA Transposable Elements, DNA, Bacterial, Genes, Bacterial, Humans, Microbial Sensitivity Tests, Models, Biological, Mutation, Staphylococcal Infections, Staphylococcus aureus, Virulence, Vancomycin Resistance, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review